FDA has already approved new novel therapies in 2025, unlocking new possibilities in oncology, neurology, rare diseases, and pain management.
From gene-targeted treatments to advanced siRNA and antibody-drug conjugates, the drug discovery landscape is expanding fast, making it a prime time for pharmacy and life science professionals to explore careers in clinical research, regulatory affairs, pharmacovigilance, and biotech R&D.
Each new approval is not just a treatment—it’s a career pathway opening up.
Innovation is booming. Are you ready to grow with it?